Form D · Biotechnology
Bio-Tech Medical Software, Inc.
Ft. Lauderdale, FL · CIK 0001516848
Offering snapshot reported Apr 3, 2015 · SEC filing
- Reported sold
- $3M Offering amount: $5M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Apr 3, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 3, 2015 | Amendment | $3,000,000 | No comparison | 0 | SEC filing |
| Nov 5, 2014 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Apr 4, 2011 | Initial | $200,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0 (estimated)
- Finders' fees
- $0
- Form D file number
- 021-227714
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| N/A | None |
Source: Form D, filed Apr 3, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Frank Biller | Director, Executive |
| Terrence Ferraro | Director, Executive |
| Stephen Siegel | Director, Executive |
| Steven Siegel | Director, Executive |
| Patrick Vo | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3101 N. Federal Highway Suite 400
Ft. Lauderdale, FL, 33324
Ft. Lauderdale, FL, 33324